Fig. 9From: Transcription factors-related molecular subtypes and risk prognostic model: exploring the immunogenicity landscape and potential drug targets in hepatocellular carcinomaMolecular docking analyses. Predicted binding sites between trametinib and nine TFs. Orange represents DNA, blue represents protein, light blue represents Trametinib, and yellow represents the residue of drug docking. Red dotted lines represent possible hydrogen bondsBack to article page